Post-COVID Surge Manufacturing Progress

Source: Cytiva

In this segment of the Bioprocess Online Live event, Surge Manufacturing for Biopharma Resilience, University of Sheffield’s Dr. Zoltán Kis and TFF Pharmaceuticals’ Kayla Hannon discuss the rapid adoption of surge manufacturing principles like single use and modular design process trains in post-COVID biopharma scale-up and scale-out.

View the full presentation here.


access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online